Storia in 5 fonti

Gene-editing drugs are opening a new frontier in medicine

Medicines that we take only a few times and which permanently alter the trajectory of our lives for the better, are on the way.

Raccontata daendpoints.newsspectator.commedpagetoday.comarstechnica.comhealio.com

Confronto fonti

5 prospettive sulla stessa storia

AI · summaries

spectator.comStai leggendo1 mesi fa

Gene-editing drugs are opening a new frontier in medicine

Medicines that we take only a few times and which permanently alter the trajectory of our lives for the better, are on the way.

originale

arstechnica.com1 mesi fa

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.

Leggi questa versione → originale

healio.com1 mesi fa

PCSK9 inhibition via base editing lowers LDL in patients with genetic high cholesterol

Genetic PCSK9 inhibition via base editing appeared safe and demonstrated dose-dependent, durable reductions in PCSK9 and LDL cholesterol, researchers reported.At the highest dose, VERVE-102 (Verve Therapeutics) was…

Leggi questa versione → originale

endpoints.news1 mesi fa

Lilly reports new data on PCSK9 base editing gene therapy from Verve buyout

Eli Lilly said a base editing gene therapy from its purchase of Verve Therapeutics delivered additional positive results in a Phase 1b trial, paving the way for a mid-stage test by year’s end.

Leggi questa versione → originale

medpagetoday.com1 mesi fa

So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia

Tweaked lipid nanoparticle delivery system showed early safety

Leggi questa versione → originale

Timeline cronologica

1. martedì 26 maggio 2026·endpoints.news
   

   Lilly reports new data on PCSK9 base editing gene therapy from Verve buyout

   Eli Lilly said a base editing gene therapy from its purchase of Verve Therapeutics delivered additional positive results in a Phase 1b trial, paving the way for a mid-stage test…

2. martedì 26 maggio 2026·spectator.com
   

   Gene-editing drugs are opening a new frontier in medicine

   Medicines that we take only a few times and which permanently alter the trajectory of our lives for the better, are on the way.

3. martedì 26 maggio 2026·medpagetoday.com
   

   So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia

   Tweaked lipid nanoparticle delivery system showed early safety

4. giovedì 28 maggio 2026·arstechnica.com
   

   Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

   The interim Phase I trial data was only from 35 people, but results look good so far.

5. giovedì 28 maggio 2026·arstechnica.com
   

   One dose of gene-editing drug cut bad cholesterol 62% for months in small trial

   The interim Phase I trial data was only from 35 people, but results look good so far.

6. venerdì 29 maggio 2026·healio.com
   

   PCSK9 inhibition via base editing lowers LDL in patients with genetic high cholesterol

   Genetic PCSK9 inhibition via base editing appeared safe and demonstrated dose-dependent, durable reductions in PCSK9 and LDL cholesterol, researchers reported.At the highest dose,…